Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies (MDX1106-03)

This study is ongoing, but not recruiting participants.
Ono Pharmaceutical Company, Ltd.
Information provided by (Responsible Party):
Bristol-Myers Squibb Identifier:
First received: August 4, 2008
Last updated: February 19, 2015
Last verified: May 2014